2025 SPONSORS

 For five decades Alpha Laboratories has been providing quality supply and support to UK and international scientists for their diagnostic and laboratory product needs. The company remains today, as always, a family run business with the same vision and ethos: “Alpha Laboratories is passionate about finding new and sustainable ways to help science improve people’s lives by developing innovative Diagnostic and Laboratory solutions.” A long history of working with the National Bowel Screening Programmes, led to supporting progress to more advanced Faecal Immunochemical Testing (FIT) for both screening and symptomatic applications. Alongside this we have championed the use of calprotectin assays to diagnose and monitor Inflammatory Bowel Diseases (IBD), without the need for costly and invasive endoscopy. Our expertise in these areas enables us to support gastroenterology clinicians alongside laboratory scientists in providing patient centric, cost-efficient solutions that improve workflows and provide high quality results for diagnosis and disease management.

BIOHIT Healthcare Ltd is the UK subsidiary of BIOHIT Oyj, a Finnish biotechnology company specialising in the development, manufacture and marketing of products and analysis systems for the early diagnosis and prevention of gastrointestinal diseases.

We specialise in digestive disease diagnostics, offering a portfolio of unique and patented tests designed to transform clinical practice by making screening, diagnosis and monitoring of gastrointestinal diseases more efficient and cost effective. Non-invasive diagnostics are at the core of our offering, making BIOHIT the provider of choice for leading gastroenterologists and laboratory scientists across the UK.

Key products in our portfolio include Ultra-fast Urease Tests, SmarTest® Calprotectin Home and GastroPanel® for the early diagnosis of gastric cancer risk.

Visit biohithealthcare.co.uk to view our full product range and access our educational blog series and resources.

Sponsor bio coming soon!

In the meantime, find out more about Calmoseptine HERE

Crohn's & Colitis UK is the leading charity for Crohn’s Disease and Ulcerative Colitis, the two main forms of Inflammatory Bowel Disease. These are lifelong conditions for which there is no cure, and they affect more than 540,000 people in the UK.

Every year, 25,000 people are told that they have Crohn’s or Colitis. For some, the news comes as a shock. For others, it has taken many years to get that diagnosis. However the news comes, it is life-changing.

People affected by the conditions look to Crohn’s & Colitis UK for much-needed support and information. We are here to raise awareness, end taboos, and ensure that everyone living with Crohn’s or Colitis feels seen, heard and understood.

Our work with healthcare professionals has helped improve the diagnosis, treatment and management of Inflammatory Bowel Disease. But there is more to do, and we continue to advocate for the IBD community.

Data4NHS maintains one of the largest healthcare related databases in the UK.  Formerly known as the Blue Book, Data4NHS has been compiling data on the NHS since 1992. This established and trusted resource contains up-to-date, accurate and in-depth information relating to a variety of healthcare professionals working for and supporting the NHS.  Registration is free and only available to NHS professionals with a valid NHS email address.  Register with us to have access to our resources including the Data4NHS national directory, recruitment opportunities, events and courses calendar, surveys and e-bulletin.

Lilly is a medicine company turning science into therapies to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are advancing new discoveries to address some of the world's most significant health challenges: redefining diabetes and obesity care; advancing the fight against Alzheimer's disease; providing options for debilitating immune system disorders; and transforming the management of difficult-to-treat cancers. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly UK or Eli Lilly and Company UK & Ireland: Overview | LinkedIn

The Royal Marsden Conference Team organises world-class medical conferences, study and training days for The Royal Marsden NHS Foundation Trust and other healthcare institutions. We offer an experienced and dedicated event management team who organise conferences and study days both at The Royal Marsden and externally.